FAK1_HUMAN - dbPTM
FAK1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID FAK1_HUMAN
UniProt AC Q05397
Protein Name Focal adhesion kinase 1
Gene Name PTK2
Organism Homo sapiens (Human).
Sequence Length 1052
Subcellular Localization Cell junction, focal adhesion. Cell membrane
Peripheral membrane protein
Cytoplasmic side. Cytoplasm, cell cortex. Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Nucleus. Constituent of focal adhesions.
Protein Description Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse formation; required for normal development of the nervous system. Plays a role in osteogenesis and differentiation of osteoblasts. Functions in integrin signal transduction, but also in signaling downstream of numerous growth factor receptors, G-protein coupled receptors (GPCR), EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling cascade. Promotes localized and transient activation of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), and thereby modulates the activity of Rho family GTPases. Signaling via CAS family members mediates activation of RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes phosphorylation of PXN and STAT1; most likely PXN and STAT1 are phosphorylated by a SRC family kinase that is recruited to autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1. Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription..
Protein Sequence MAAAYLDPNLNHTPNSSTKTHLGTGMERSPGAMERVLKVFHYFESNSEPTTWASIIRHGDATDVRGIIQKIVDSHKVKHVACYGFRLSHLRSEEVHWLHVDMGVSSVREKYELAHPPEEWKYELRIRYLPKGFLNQFTEDKPTLNFFYQQVKSDYMLEIADQVDQEIALKLGCLEIRRSYWEMRGNALEKKSNYEVLEKDVGLKRFFPKSLLDSVKAKTLRKLIQQTFRQFANLNREESILKFFEILSPVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGCNPTHLADFTQVQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGTSQSFIIRPQKEGERALPSIPKLANSEKQGMRTHAVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEERMRMESRRQATVSWDSGGSDEAPPKPSRPGYPSPRSSEGFYPSPQHMVQTNHYQVSGYPGSHGITAMAGSIYPGQASLLDQTDSWNHRPQEIAMWQPNVEDSTVLDLRGIGQVLPTHLMEERLIRQQQEMEEDQRWLEKEERFLKPDVRLSRGSIDREDGSLQGPIGNQHIYQPVGKPDPAAPPKKPPRPGAPGHLGSLASLSSPADSYNEGVKLQPQEISPPPTANLDRSNDKVYENVTGLVKAVIEMSSKIQPAPPEEYVPMVKEVGLALRTLLATVDETIPLLPASTHREIEMAQKLLNSDLGELINKMKLAQQYVMTSLQQEYKKQMLTAAHALAVDAKNLLDVIDQARLKMLGQTRPH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAAYLDPN
------CCCCCCCCC
16.4719369195
5Phosphorylation---MAAAYLDPNLNH
---CCCCCCCCCCCC
13.6025159151
13PhosphorylationLDPNLNHTPNSSTKT
CCCCCCCCCCCCCCC
24.0825159151
16PhosphorylationNLNHTPNSSTKTHLG
CCCCCCCCCCCCCCC
40.3625159151
17PhosphorylationLNHTPNSSTKTHLGT
CCCCCCCCCCCCCCC
40.3322199227
18PhosphorylationNHTPNSSTKTHLGTG
CCCCCCCCCCCCCCC
39.5222199227
20PhosphorylationTPNSSTKTHLGTGME
CCCCCCCCCCCCCCC
23.5623403867
24PhosphorylationSTKTHLGTGMERSPG
CCCCCCCCCCCCCCC
39.4527696853
29PhosphorylationLGTGMERSPGAMERV
CCCCCCCCCCHHHHH
17.8725159151
54PhosphorylationSEPTTWASIIRHGDA
CCCCCHHHHHHCCCC
15.31-
65MethylationHGDATDVRGIIQKIV
CCCCCCHHHHHHHHH
33.14-
70UbiquitinationDVRGIIQKIVDSHKV
CHHHHHHHHHHCCCC
34.00-
131SumoylationLRIRYLPKGFLNQFT
EEEEECCCCHHHHHC
60.75-
131SumoylationLRIRYLPKGFLNQFT
EEEEECCCCHHHHHC
60.7514500712
148PhosphorylationKPTLNFFYQQVKSDY
CCCHHHHHHHHCCCH
8.2217117420
152SumoylationNFFYQQVKSDYMLEI
HHHHHHHCCCHHHHH
33.02-
155PhosphorylationYQQVKSDYMLEIADQ
HHHHCCCHHHHHHHH
15.6417117420
194PhosphorylationALEKKSNYEVLEKDV
HHHHHCCHHHHHHHH
17.9520802513
199UbiquitinationSNYEVLEKDVGLKRF
CCHHHHHHHHCCHHH
54.26-
216UbiquitinationKSLLDSVKAKTLRKL
HHHHHHHHHHHHHHH
48.38-
222MalonylationVKAKTLRKLIQQTFR
HHHHHHHHHHHHHHH
53.7226320211
239PhosphorylationANLNREESILKFFEI
HCCCHHHHHHHHHHH
28.5924719451
248PhosphorylationLKFFEILSPVYRFDK
HHHHHHHCCHHCCCH
20.2721406692
251PhosphorylationFEILSPVYRFDKECF
HHHHCCHHCCCHHHH
14.6721406692
347PhosphorylationMADLIDGYCRLVNGT
HHHHHHHCHHHHCCC
3.1711853674
364UbiquitinationSFIIRPQKEGERALP
CEEECCCCCCCCCCC
71.07-
372PhosphorylationEGERALPSIPKLANS
CCCCCCCCCHHHCCC
52.9923532336
386PhosphorylationSEKQGMRTHAVSVSE
CCCCCCCCEEEEECC
12.8028176443
390PhosphorylationGMRTHAVSVSETDDY
CCCCEEEEECCCCCC
22.2522322096
392PhosphorylationRTHAVSVSETDDYAE
CCEEEEECCCCCCHH
27.5428176443
394PhosphorylationHAVSVSETDDYAEII
EEEEECCCCCCHHCC
27.0228176443
397DephosphorylationSVSETDDYAEIIDEE
EECCCCCCHHCCCCC
14.6711314030
397PhosphorylationSVSETDDYAEIIDEE
EECCCCCCHHCCCCC
14.6712754219
406PhosphorylationEIIDEEDTYTMPSTR
HCCCCCCCCCCCCCC
24.9528176443
407PhosphorylationIIDEEDTYTMPSTRD
CCCCCCCCCCCCCCC
17.2317449913
408PhosphorylationIDEEDTYTMPSTRDY
CCCCCCCCCCCCCCH
25.3818691976
411PhosphorylationEDTYTMPSTRDYEIQ
CCCCCCCCCCCHHHH
25.8326356563
412PhosphorylationDTYTMPSTRDYEIQR
CCCCCCCCCCHHHHH
22.9926356563
441PhosphorylationGDVHQGIYMSPENPA
CCCCCCEEECCCCHH
9.8127259358
443PhosphorylationVHQGIYMSPENPALA
CCCCEEECCCCHHHH
16.4626356563
460PhosphorylationIKTCKNCTSDSVREK
HHHCCCCCCHHHHHH
44.99-
461PhosphorylationKTCKNCTSDSVREKF
HHCCCCCCHHHHHHH
30.04-
463PhosphorylationCKNCTSDSVREKFLQ
CCCCCCHHHHHHHHH
23.88-
467AcetylationTSDSVREKFLQEALT
CCHHHHHHHHHHHHH
40.5919828921
474PhosphorylationKFLQEALTMRQFDHP
HHHHHHHHHHHCCCC
19.84-
503PhosphorylationWIIMELCTLGELRSF
HHHHHHCCHHHHHHH
50.8817117420
517PhosphorylationFLQVRKYSLDLASLI
HHHHHHHHHHHHHHH
20.6020860994
522PhosphorylationKYSLDLASLILYAYQ
HHHHHHHHHHHHHHH
24.2020860994
526PhosphorylationDLASLILYAYQLSTA
HHHHHHHHHHHHHHH
9.0320860994
568PhosphorylationKLGDFGLSRYMEDST
EECCCCHHHHHCCCC
23.0329255136
570PhosphorylationGDFGLSRYMEDSTYY
CCCCHHHHHCCCCEE
11.0721945579
574PhosphorylationLSRYMEDSTYYKASK
HHHHHCCCCEECCCC
12.6621945579
575PhosphorylationSRYMEDSTYYKASKG
HHHHCCCCEECCCCC
43.1021945579
576PhosphorylationRYMEDSTYYKASKGK
HHHCCCCEECCCCCC
13.6119664994
577PhosphorylationYMEDSTYYKASKGKL
HHCCCCEECCCCCCC
10.5217449913
580PhosphorylationDSTYYKASKGKLPIK
CCCEECCCCCCCCCE
37.4827273156
677PhosphorylationTELKAQLSTILEEEK
HHHHHHHHHHHHHHH
11.0030624053
678PhosphorylationELKAQLSTILEEEKA
HHHHHHHHHHHHHHH
37.8730624053
684UbiquitinationSTILEEEKAQQEERM
HHHHHHHHHHHHHHH
55.57-
688 (in isoform 2)Phosphorylation-35.1728796482
695PhosphorylationEERMRMESRRQATVS
HHHHHHHHHHHCEEC
24.34-
700PhosphorylationMESRRQATVSWDSGG
HHHHHHCEECCCCCC
13.5123663014
702PhosphorylationSRRQATVSWDSGGSD
HHHHCEECCCCCCCC
22.3223927012
705PhosphorylationQATVSWDSGGSDEAP
HCEECCCCCCCCCCC
38.5023927012
708PhosphorylationVSWDSGGSDEAPPKP
ECCCCCCCCCCCCCC
35.4823927012
716PhosphorylationDEAPPKPSRPGYPSP
CCCCCCCCCCCCCCC
58.1830266825
720PhosphorylationPKPSRPGYPSPRSSE
CCCCCCCCCCCCCCC
11.8323927012
722PhosphorylationPSRPGYPSPRSSEGF
CCCCCCCCCCCCCCC
25.1819664994
725 (in isoform 7)Phosphorylation-35.8022210691
726PhosphorylationGYPSPRSSEGFYPSP
CCCCCCCCCCCCCCC
42.91-
726 (in isoform 7)Phosphorylation-42.9122210691
732PhosphorylationSSEGFYPSPQHMVQT
CCCCCCCCCCCEEEE
26.3017096371
742PhosphorylationHMVQTNHYQVSGYPG
CEEEECCEECCCCCC
16.81-
759PhosphorylationGITAMAGSIYPGQAS
CEEEEECCCCCCCHH
14.92-
759 (in isoform 7)Phosphorylation-14.9222210691
761PhosphorylationTAMAGSIYPGQASLL
EEEECCCCCCCHHHH
11.74-
805PhosphorylationGIGQVLPTHLMEERL
CCCHHHCHHHHHHHH
24.3917855441
840PhosphorylationLKPDVRLSRGSIDRE
CCCCCEECCCCCCCC
24.8328355574
843PhosphorylationDVRLSRGSIDREDGS
CCEECCCCCCCCCCC
21.8721945579
850PhosphorylationSIDREDGSLQGPIGN
CCCCCCCCEECCCCC
29.8221945579
861PhosphorylationPIGNQHIYQPVGKPD
CCCCEEEECCCCCCC
12.4917449913
861 (in isoform 5)Phosphorylation-12.49-
887PhosphorylationGAPGHLGSLASLSSP
CCCCCHHHHHHCCCC
27.4221082442
890PhosphorylationGHLGSLASLSSPADS
CCHHHHHHCCCCCCC
33.7926356563
892PhosphorylationLGSLASLSSPADSYN
HHHHHHCCCCCCCCC
31.6126356563
893PhosphorylationGSLASLSSPADSYNE
HHHHHCCCCCCCCCC
29.4229496963
897PhosphorylationSLSSPADSYNEGVKL
HCCCCCCCCCCCCCC
31.7823186163
898PhosphorylationLSSPADSYNEGVKLQ
CCCCCCCCCCCCCCC
20.1325884760
910PhosphorylationKLQPQEISPPPTANL
CCCCCCCCCCCCCCC
30.5117096371
914PhosphorylationQEISPPPTANLDRSN
CCCCCCCCCCCCCCC
33.6723927012
920PhosphorylationPTANLDRSNDKVYEN
CCCCCCCCCCHHHHC
49.3928152594
923UbiquitinationNLDRSNDKVYENVTG
CCCCCCCHHHHCHHH
51.47-
923 (in isoform 5)Phosphorylation-51.4730087585
925PhosphorylationDRSNDKVYENVTGLV
CCCCCHHHHCHHHHH
13.9212754219
929PhosphorylationDKVYENVTGLVKAVI
CHHHHCHHHHHHHHH
36.0628152594
963PhosphorylationEVGLALRTLLATVDE
HHHHHHHHHHHHHCC
27.29-
967PhosphorylationALRTLLATVDETIPL
HHHHHHHHHCCCCCC
28.58-
971PhosphorylationLLATVDETIPLLPAS
HHHHHCCCCCCCCCC
24.35-
1000UbiquitinationDLGELINKMKLAQQY
CHHHHHHHHHHHHHH
30.34-
1007PhosphorylationKMKLAQQYVMTSLQQ
HHHHHHHHHHHHHHH
4.7017117420
1016PhosphorylationMTSLQQEYKKQMLTA
HHHHHHHHHHHHHHH
21.1018083107
1017AcetylationTSLQQEYKKQMLTAA
HHHHHHHHHHHHHHH
35.4624179899

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
5YPhosphorylationKinaseEGFRP00533
PSP
5YPhosphorylationKinaseMETP08581
PSP
5YPhosphorylationKinasePDGFRBP09619
PSP
194YPhosphorylationKinaseMETP08581
PSP
194YPhosphorylationKinaseEGFRP00533
PSP
194YPhosphorylationKinasePDGFRBP09619
PSP
194YPhosphorylationKinaseBMXP51813
GPS
194YPhosphorylationKinaseSRCP12931
PSP
397YPhosphorylationKinaseMETP08581
PSP
397YPhosphorylationKinaseSRCP12931
PSP
397YPhosphorylationKinasePTK2Q05397
GPS
397YPhosphorylationKinaseFGRP09769
PSP
407YPhosphorylationKinaseSRCP12931
PSP
407YPhosphorylationKinaseMETP08581
PSP
407YPhosphorylationKinasePTK2Q05397
GPS
407YPhosphorylationKinasePTK2BQ14289
GPS
441YPhosphorylationKinaseBMXP51813
GPS
441YPhosphorylationKinaseSRCP12931
PSP
576YPhosphorylationKinaseMETP08581
PSP
576YPhosphorylationKinaseFGRP09769
PSP
576YPhosphorylationKinaseRETP07949
Uniprot
576YPhosphorylationKinasePTK2Q05397
GPS
576YPhosphorylationKinaseSRCP12931
Uniprot
576YPhosphorylationKinaseBMXP51813
GPS
577YPhosphorylationKinasePTK2Q05397
GPS
577YPhosphorylationKinaseRETP07949
Uniprot
577YPhosphorylationKinaseMETP08581
PSP
577YPhosphorylationKinaseSRCP12931
Uniprot
577YPhosphorylationKinaseBMXP51813
GPS
695SPhosphorylationKinaseAKT1P31749
PSP
700TPhosphorylationKinaseAKT1P31749
PSP
732SPhosphorylationKinaseROCK1Q13464
PSP
732SPhosphorylationKinaseCDK5Q00535
Uniprot
742YPhosphorylationKinaseBMXP51813
GPS
742YPhosphorylationKinaseSRCP12931
PSP
861YPhosphorylationKinaseMETP08581
PSP
861YPhosphorylationKinaseSRC64-PhosphoELM
861YPhosphorylationKinaseYES1P07947
GPS
861YPhosphorylationKinaseRETP07949
PSP
861YPhosphorylationKinaseBMXP51813
GPS
861YPhosphorylationKinaseSRCP12931
PSP
898YPhosphorylationKinaseSRCP12931
PSP
898YPhosphorylationKinaseBMXP51813
GPS
910SPhosphorylationKinaseCDK5Q00535
PSP
925YPhosphorylationKinaseMETP08581
PSP
925YPhosphorylationKinaseYES1P07947
GPS
925YPhosphorylationKinaseBMXP51813
GPS
925YPhosphorylationKinaseSRCP12931
PSP
925YPhosphorylationKinaseRETP07949
PSP
925YPhosphorylationKinaseFGRP09769
PSP
1007YPhosphorylationKinaseSRCP12931
PSP
1007YPhosphorylationKinaseBMXP51813
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
722SPhosphorylation

19339212

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of FAK1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
IRS1_HUMANIRS1physical
9822703
SOCS2_HUMANSOCS2physical
16189514
ATG12_HUMANATG12physical
16189514
BCAR1_HUMANBCAR1physical
12615911
DOCK1_HUMANDOCK1physical
12615911
SRC_HUMANSRCphysical
12615911
CRK_HUMANCRKphysical
12615911
JIP3_HUMANMAPK8IP3physical
12226752
EGFR_HUMANEGFRphysical
10806474
JAK2_HUMANJAK2physical
9553131
STAT1_HUMANSTAT1physical
11278462
TGFI1_HUMANTGFB1I1physical
9422762
PAXI_HUMANPXNphysical
9422762
CCR5_HUMANCCR5physical
10384144
CXCR4_HUMANCXCR4physical
11668182
TSC1_HUMANTSC1physical
17043358
TSC2_HUMANTSC2physical
17043358
PTN11_HUMANPTPN11physical
10082579
EPHA2_HUMANEPHA2physical
10655584
PAXI_HUMANPXNphysical
11919182
ITA4_HUMANITGA4physical
11919182
SRC_HUMANSRCphysical
12387730
FGR_HUMANFGRphysical
12387730
TLN1_HUMANTLN1physical
9442086
PAXI_HUMANPXNphysical
9442086
SRC_HUMANSRCphysical
12558988
GRB2_HUMANGRB2physical
12558988
AMPH_HUMANAMPHphysical
12558988
BIN1_HUMANBIN1physical
12558988
FYN_HUMANFYNphysical
12558988
YES_HUMANYES1physical
12558988
CASL_HUMANNEDD9physical
8668148
JAK2_HUMANJAK2physical
10925297
STAT3_HUMANSTAT3physical
10925297
PP1B_HUMANPPP1CBphysical
11513739
FAK1_HUMANPTK2physical
12005431
KSYK_HUMANSYKphysical
9169439
LYN_HUMANLYNphysical
9169439
P85A_HUMANPIK3R1physical
7537275
KSYK_HUMANSYKphysical
9342235
FYN_HUMANFYNphysical
11278857
BCAR1_HUMANBCAR1physical
12135674
BCAR1_HUMANBCAR1physical
10753828
PAXI_HUMANPXNphysical
10753828
SRC_HUMANSRCphysical
9822703
DCC_HUMANDCCphysical
15494733
NEO1_HUMANNEO1physical
15494733
G3P_HUMANGAPDHphysical
18206965
PARP1_HUMANPARP1physical
18206965
P53_HUMANTP53physical
18206965
MDM2_HUMANMDM2physical
18206965
SOCS3_HUMANSOCS3physical
18031698
HES1_HUMANHES1physical
21900206
NASP_HUMANNASPphysical
21900206
F16P1_HUMANFBP1physical
21900206
F13A_HUMANF13A1physical
21900206
BBS10_HUMANBBS10physical
21900206
NACAD_HUMANNACADphysical
21900206
EF1G_HUMANEEF1Gphysical
21900206
DX39A_HUMANDDX39Aphysical
21900206
ZN331_HUMANZNF331physical
21900206
TGFI1_HUMANTGFB1I1physical
21900206
ES8L2_HUMANEPS8L2physical
21900206
LPXN_HUMANLPXNphysical
21900206
DAG1_HUMANDAG1physical
18341635
SH3K1_HUMANSH3KBP1physical
12771190
PDC6I_HUMANPDCD6IPphysical
12771190
CBL_HUMANCBLphysical
12771190
ASAP1_HUMANASAP1physical
17893324
BCAR1_HUMANBCAR1physical
21855630
SRC_HUMANSRCphysical
21855630
STAP2_HUMANSTAP2physical
17675501
CHIP_HUMANSTUB1physical
22734001
STAT1_HUMANSTAT1physical
20576130
SOCS3_HUMANSOCS3physical
16007195
A4_HUMANAPPphysical
21832049
PTH2_HUMANPTRH2physical
21383007
SAE1_HUMANSAE1physical
21988832
PAXI_HUMANPXNphysical
10980697
TRI72_HUMANTRIM72physical
24344130
UBE2H_HUMANUBE2Hphysical
24344130
YES_HUMANYES1physical
25416956
SOCS3_HUMANSOCS3physical
25416956
DEFI6_HUMANDEF6physical
25416956
TRM6_HUMANTRMT6physical
26344197
GRB7_HUMANGRB7physical
25814554
HCK_HUMANHCKphysical
25814554
PKD1_HUMANPKD1physical
11113628
SRC_HUMANSRCphysical
25241761
ERBB2_HUMANERBB2physical
25241761
P53_HUMANTP53physical
25241761
CCNA1_HUMANCCNA1physical
25241761
PIAS1_HUMANPIAS1physical
25241761
STAT3_HUMANSTAT3physical
25241761
RET_HUMANRETphysical
25241761
APC_HUMANAPCphysical
25241761
PTEN_HUMANPTENphysical
9927060
ERBB2_HUMANERBB2physical
12600989
P85A_HUMANPIK3R1physical
10973983
ITB1_HUMANITGB1physical
25792870

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of FAK1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-5; THR-13; SER-16;SER-29; THR-386; SER-390; SER-392; THR-394; TYR-397; THR-406; TYR-407;TYR-570; THR-575; TYR-576; TYR-577; SER-580; SER-677; THR-700;SER-702; SER-705; SER-708; SER-716; TYR-720; SER-722; SER-840;SER-843; TYR-861 AND SER-910, PHOSPHORYLATION [LARGE SCALE ANALYSIS]AT TYR-688 (ISOFORM 2), AND MASS SPECTROMETRY.
"Specific tyrosine phosphorylation of focal adhesion kinase mediatedby Fer tyrosine kinase in suspended hepatocytes.";
Oh M.A., Choi S., Lee M.J., Choi M.C., Lee S.A., Ko W., Cance W.G.,Oh E.S., Buday L., Kim S.H., Lee J.W.;
Biochim. Biophys. Acta 1793:781-791(2009).
Cited for: PHOSPHORYLATION AT TYR-397; TYR-576; TYR-577; SER-722; TYR-861 ANDTYR-925, AND IDENTIFICATION IN A COMPLEX WITH CTTN AND FER.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-29; SER-568;TYR-570; SER-722; SER-840; SER-887 AND SER-910, AND MASS SPECTROMETRY.
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry.";
Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.;
Mol. Cell. Proteomics 6:537-547(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397; TYR-576; SER-722;SER-840; SER-843 AND SER-910, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397 AND SER-840, ANDMASS SPECTROMETRY.
"Focal adhesion kinase (FAK) binds RET kinase via its FERM domain,priming a direct and reciprocal RET-FAK transactivation mechanism.";
Plaza-Menacho I., Morandi A., Mologni L., Boender P.,Gambacorti-Passerini C., Magee A.I., Hofstra R.M.W., Knowles P.,McDonald N.Q., Isacke C.M.;
J. Biol. Chem. 286:17292-17302(2011).
Cited for: INTERACTION WITH RET, FUNCTION IN RET PHOSPHORYLATION, ANDPHOSPHORYLATION AT TYR-576 AND TYR-577.
"ZF21 protein regulates cell adhesion and motility.";
Nagano M., Hoshino D., Sakamoto T., Kawasaki N., Koshikawa N.,Seiki M.;
J. Biol. Chem. 285:21013-21022(2010).
Cited for: INTERACTION WITH ZFYVE21, AND DEPHOSPHORYLATION AT TYR-397.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576; TYR-577 ANDTYR-861, AND MASS SPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576, AND MASSSPECTROMETRY.
"Inhibition of both focal adhesion kinase and insulin-like growthfactor-I receptor kinase suppresses glioma proliferation in vitro andin vivo.";
Liu T.J., LaFortune T., Honda T., Ohmori O., Hatakeyama S., Meyer T.,Jackson D., de Groot J., Yung W.K.;
Mol. Cancer Ther. 6:1357-1367(2007).
Cited for: FUNCTION, ENZYME REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION ATTYR-397.
"Cellular characterization of a novel focal adhesion kinaseinhibitor.";
Slack-Davis J.K., Martin K.H., Tilghman R.W., Iwanicki M., Ung E.J.,Autry C., Luzzio M.J., Cooper B., Kath J.C., Roberts W.G.,Parsons J.T.;
J. Biol. Chem. 282:14845-14852(2007).
Cited for: FUNCTION, ENZYME REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION ATTYR-397.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397; TYR-570; TYR-576;TYR-577 AND TYR-861, AND MASS SPECTROMETRY.
"Therapeutic efficacy of a novel focal adhesion kinase inhibitorTAE226 in ovarian carcinoma.";
Halder J., Lin Y.G., Merritt W.M., Spannuth W.A., Nick A.M., Honda T.,Kamat A.A., Han L.Y., Kim T.J., Lu C., Tari A.M., Bornmann W.,Fernandez A., Lopez-Berestein G., Sood A.K.;
Cancer Res. 67:10976-10983(2007).
Cited for: ENZYME REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION AT TYR-397 ANDTYR-861.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576, AND MASSSPECTROMETRY.
"The proto-oncogene Fgr regulates cell migration and this requires itsplasma membrane localization.";
Continolo S., Baruzzi A., Majeed M., Caveggion E., Fumagalli L.,Lowell C.A., Berton G.;
Exp. Cell Res. 302:253-269(2005).
Cited for: FUNCTION IN REGULATION OF CELL MIGRATION, AND PHOSPHORYLATION ATTYR-407; TYR-397 AND TYR-576.
"Site-specific phosphorylation of platelet focal adhesion kinase bylow-density lipoprotein.";
Relou I.A.M., Bax L.A.B., Van Rijn H.J.M., Akkerman J.-W.N.;
Biochem. J. 369:407-416(2003).
Cited for: PHOSPHORYLATION AT TYR-397; TYR-407; TYR-577; TYR-861 AND TYR-925, ANDINTERACTION WITH FGR.

TOP